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Scope: The human/microbiota cross-talk is partially mediated by bacteria-derived peptides
like Serine-Threonine peptide (STp), which is resistant to gut proteolysis, is found in the
human healthy colon and induces regulatory properties on gut dendritic cells (DCs); here we
characterized human gut DC in ulcerative colitis (UC) patients and studied the effect of STp
on their properties.
Methods and results: Human colonic DC from healthy controls and UC patients were isolated,
conditioned for 24 h +/− STp and characterized by flow cytometry, immunohistochemistry,
and electron microscopy. Expression of immature DC markers DC-SIGN and ILT3, and Toll-
like receptors were increased on gut UC-DC. Langerin (involved in phagocytosis), lymph node
homing marker CCR7, and activation markers CD40/CD80/CD86 were decreased in UC. Gut
DC had restricted stimulatory capacity for T-cells in UC. Conditioning of DC with STp in vitro
reduced Toll-like receptor expression, increased CD40 and CD80 expression, and restored their
stimulatory capacity.
Conclusion: Colonic DCs display an abnormal immature phenotype in UC, which was partially
restored following STp treatment. Bacteria-derived metabolites, like STp, seem to have a role
in gut homeostasis that is missing in UC so they might lead a new era of probiotic products
setting the basis for nondrug dietary therapy in inflammatory bowel disease.
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1 Introduction
Ulcerative colitis (UC) results from inappropriate mucosal
immune responses to constituents of the intestinal flora in
genetically predisposed individuals [1]. Antigen-presenting
cells such as dendritic cells (DCs) are likely to play a central
role in the host response to intestinal flora, both in innate
responses to bacteria and by shaping the properties of adap-
tive immune responses [2]. Indeed, DCs are key initiators
of innate immune responses and the only cells capable of
generating primary T-cell responses [3].
Intestinal DCs are present within Peyer’s patches and
distributed throughout the lamina propria (LP), and main-
tain the delicate balance in the gut between immunogenicity
against invading pathogens and tolerance of the commensal
microbiota.Disruption of this balance can result in inflamma-
tory bowel disease (IBD) [4, 5]. In health, homeostatic effects
of commensal microenvironment are not, therefore, merely
providing a “tolerogenic” milieu but contribute a balance be-
tween pro-inflammatory and anti-inflammatory responses.
Responses of DC to microbial antigens are enabled partly
through their rich supply of pattern recognition receptors
such as Toll-like receptors (TLRs), which recognize structural
elements on bacterial cell surfaces [6]. Intestinal immune
tolerance is initiated by immature DCs that induce anergic
T-cells [7]. Upon DC activation lymph node homing marker
C-chemokine receptor 7 (CCR7) is upregulated on DC en-
abling migration to secondary lymphoid tissue in order to
generate primary T-cell responses [8]. These T-cell responses
generated can be immunogenic or tolerogenic [3,9], but prop-
erties of healthy gut DCs suggest that in the steady state, gut
DCs have a homeostatic role, likely to be due to the high
antigenic load including the gut microbiota and food anti-
gens. SuchDC properties include hyporesponsiveness to LPS
stimulation [10], high constitutive production of regulatory cy-
tokine IL-10 and low production of inflammatory IL-12, low
expression of costimulatory molecules and TLRs [11], and a
restricted capacity to stimulate T-cells [12]. Altered DC phe-
notype and function in UC suggests that they contribute to
UC pathogenesis [5, 13, 14].
The intestinal microbiota is altered in patients with active
UC compared with that of healthy individuals [15,16]. Manip-
ulating gut flora using probiotics may correct and/or prevent
dysregulated immune function in UC; the effects of probiotic
bacteria on DC, which are so pivotal in early bacterial recog-
nition and shaping T-cell responses are likely to be central in
immunomodulation by these bacteria. The probiotic mixture
VSL#3 was effective in the treatment of patients with mild to
moderately activeUC,with a response rate of 50–70% [17] and
in animal models VSL#3 altered the phenotype and the dis-
tribution of DC in the gut mucosa in vivo [18]. Furthermore,
oral administration of VSL#3 in UC patients had direct reg-
ulatory effects on human gut DC in vivo that were likely to
contribute to therapeutic benefit [19].
There is growing interest in the immunomodulatory ef-
fects of products produced by probiotic bacteria in the gut,
as well as direct effects of bacteria themselves, partly due to
recent clinical studies that have concluded caution needs to
be taken when administering live bacteria in patients with
acute inflammation [20]. Specific strains of probiotic bacteria
can have inflammatory activities in vitro both in healthy and
IBD human tissue, but metabolic products of the same bac-
terial strains can have regulatory effects and protect against
inflammatory properties of pathogenic bacteria [21]. We re-
cently identified a peptide (serine-threonine peptide, STp)
secreted by Lactobacillus plantarum that is resistant to gut
proteolysis and present in the colon of the majority of healthy
individuals. STp induced regulatory effects on human gut DC
in vitro with knock-on effects on the T-cells that they stim-
ulated [22]. These data suggested that the molecular dialog
between intestinal bacteria and DCs may be mediated by im-
munomodulatory peptides secreted by commensal bacteria.
In this study, we aimed to investigate this further, in the con-
text of UC. Most studies supporting a role for DC in IBD are
based on animal models [23] but we have developed meth-
ods for assessing the phenotype and function of human DC,
present in small numbers in the gut, from gut biopsies [13].
2 Materials and methods
2.1 Tissues and cells
The study was approved by the Outer West London Re-
gional Ethics Committee and Imperial College London
(08/H0717/24). All patients provided written informed con-
sent on entry to the study.
2.1.1 Colonic biopsies
Colonic biopsies were obtained at colonoscopy, following in-
formed consent. Patient groups included UC patients in re-
mission (six female, six male, mean age 48 years), patients
with activeUC (12 female, 10male,mean age 52), and healthy
controls (13 female, 11 male, mean age 44). Samples were
used for different experiments as seen in the figures, so not
all the samples were used in all the experiments. Healthy
controls had macroscopically and histologically normal
intestines, undergoing colonoscopy for rectal bleeding or
family history of colorectal cancer. Diagnosis for patients with
UCwasmadeusing clinical parameters, radiographic studies,
endoscopic and histological criteria. Disease activity for UC
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was assessed using theUC disease activity index (UCDAI), all
active patients had UCDAI> 4, and all patients in remission
had UCDAI < 2. Patients were either not receiving therapy,
or were on minimal treatment: 5-aminosalicylic acid and/or
azathioprine. Biopsies were collected in ice-chilled complete
medium.
2.1.2 Intestinal DCs
Total LP cells were obtained from biopsy tissue via collage-
nase digestion, following removal ofmucus and epithelial lay-
ers via DTT/EDTA incubation, as previously described [11].
DCs were identified as HLA-DR+ lineage cocktail− (HLA-
DR+CD3−CD14−CD16−CD19−CD34−) by flow cytometry
and analyzed for surface phenotype. In some experiments,
cells were obtained by a cell migration/“walkout” method
during 20-h incubation of biopsies (37C, 5% CO2, high hu-
midity) in complete medium (RPMI 1640 (Dutch modifica-
tion; Sigma-Aldrich, Dorset, UK) supplemented with 10%
FCS, 100 mL−1 penicillin, 100 gmL−1 streptomycin and
20 mM L-glutamine after previous DTT/EDTA incubation of
freshly obtained biopsies.
2.2 STp conditioning of intestinal DCs
Gut biopsies were incubated for 20 h for the walkout method
following DTT/EDTA treatment, in complete medium with
or without 1g/mL STp, as previously described [22]. Briefly,
the gene coding for STp, including the genetic information
for a histidine tag, was cloned into pNZ9110 and introduced
in Lactococcus lactisNZ9000. Gene expression was induced by
nisin (40 ng/mL) and STp was purified from the growth su-
pernatant using Ni-NTA agarose (Qiagen Iberia S.L, Madrid,
Spain) and proper imidazole buffers for STpwashing and elu-
tion. Presence of STp was confirmed by Western-blot using a
polyclonal serum developed in rabbit. Fractions were exten-
sively dialyzed against PBS and the purified STp identified by
N-terminal degradation, preformed in a Procise 494 Protein
Sequencer (Applied Biosystems, Foster City, CA) revealing
over 99% purity as estimated by SDS-PAGE. STp was sub-
sequently lyophilized and resuspended in complete medium
before being added to the cells (negative control included ad-
dition of the same volume of complete medium—without
STp—to the cells). STp had been cloned and obtained from a
Gram-positive bacteria [22], and thereforewas LPS-free as also
confirmed following the Limulus amebocyte lysate protocol
following manufacturer’s instructions (Kinetic-QCLTM as-
say, Lonza, Basel, Switzerland). Following culture of LP cells
with and without STp, DCs were identified as HLA-DR+ lin-
eage cocktail− by flow cytometry or enriched by centrifugation
(600 × g, 15 min at RT) over NycoPrepTM, and used for T-cell
stimulation. These enriched DCs have been characterized as
functional colonic DCs [13].
2.3 Enrichment of T-cells
Peripheral blood mononuclear cells were suspended in Min-
iMACs buffer (PBS containing 0.5% BSA and 2 mM EDTA)
and T-cells were enriched by depletion of CD14+, CD19+, and
HLA-DR+ with immunomagnetic beads (Miltenyi Biotech,
Bisley, UK) following manufacturer’s instructions (over 98%
purity of CD3+ T-cells).
2.4 Proliferation assay
Carboxyfluorescein diacetate succinimidyl ester (CFSE, Invit-
rogen Ltd., UK) labeled T-cells (4 × 105/well) were incubated
for 5 days in U-bottomed 96 well microtitre plates with en-
riched intestinal allogeneic DCs at 3% in a mixed leukocyte
reaction (MLR).Cellswere recovered andCFSElo proliferating
cells identified and quantified by flow cytometry. T-cells were
also cultured in the absence of DCs, which did not proliferate
and constituted an internal negative control.
2.5 Antibody labeling
For immunohistochemistry monoclonal antibodies specific
for the following markers were used: DC-LAMP/CD208
(104.G4), CD1a (O10), and langerin/CD207 (DCGM4) were
from Beckman Coulter High Wycombe, UK. DC-SIGN/
CD209 (120507) was from R&D SYSTEMS, Oxford, UK.
Avidin biotin reagents, biotinylated goat anti-mouse IgGwere
from Vector Laboratories, Peterborough, UK.
For flow cytometry, monoclonal antibodies with the fol-
lowing specificities and conjugations were used: CD86-FITC
(24F), CD80-FITC (L307.4), CD3-PeCy5 (UCHT1), CCR7
(2H4)-PE, and HLA-DR-APC (G46–6) were purchased from
BDBiosciences (Oxford); CD11c-FITC (KB90) was purchased
from Dako (Ely, UK); CD40-FITC (LOB7/6), TLR2-FITC
(TLR2.3), TLR4-FITC (HTA125), DC exclusion cocktail-PE-
Cy5 (CD3 (S4.1), CD14 (TUK4), CD16 (3G8), CD19 (SJ25-
C1), CD34 (581) were purchased from AbD Serotec (Oxford);
DC-SIGN/CD209-PE (120507) and ILT3-PE (293623) were
purchased from R&D systems (Oxford); Langerin/CD207-
PE (DCGM4) was purchased from Beckman Coulter (High
Wycombe). Appropriate isotype-matched control antibodies
were purchased from the same manufacturers. After the
staining, cells were fixed with 1% paraformaldehyde in 0.85%
saline and stored at 4C prior to acquisition on the flow cy-
tometer, within 48 h.
2.6 Flow cytometry and data analysis
Data were acquired on a FACSCantoII (BD Biosciences) and
analyzed using WinList 5.0 software (Verity, ME).
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Figure 1. Identification and ac-
tivation status of DC in biop-
sies from healthy controls and
UC patients. (A) Intestinal LP
DCs were identified as HLA-
DR+/lineage cocktail− cells by
multicolour flow cytometry. (B)
Isotype control staining his-
tograms were subtracted from
the respective test staining
for surface markers on DC
(CD86 in this example). The
shaded areas of histograms
represent the fraction of pos-
itive cells after subtraction of
staining from isotype-matched
control (determined both as
percentage and as IR of the
identified positive cells com-
pared with the isotype labeling)
assessed by SED normalized
subtraction from the isotype
histrogram. (C) Representative
histogram for CD80 expression
following subtraction from re-
spective isotype (not shown).
(D) Expression of the costim-
ulatory molecules CD80 and
CD86 on gut DC from inactive
UC patients and healthy con-
trols displayed as the mean ±
SEM. The statistical significance
of differences between groups
was determined using unpaired
t-test and p< 0.05 was regarded
as significant (*p < 0.05).
2.7 Immunohistochemistry
The avidin-biotin complex technique was employed [24].
Briefly, slides of formalin fixed, paraffin-embedded tissue
sections of endoscopic biopsies were deparaffinized and re-
hydrated and kept moist for the rest of the procedures.
Endogenous peroxidase activity was blocked with 0.3% H2O2
in 100% methanol for 30 min. Tissues were then incubated
with normal goat serum for 30 min at room temperature
and incubated overnight in a humid atmosphere at 4C,
with primary antibodies; anti-CD1a (1:20); anti-DC-LAMP
(1:50); anti-DC-SIGN (1:200), and anti-langerin (1:100). After
washing and incubation with biotinylated goat anti-mouse
Ig for 30 min, sections were washed and incubated with
the avidin-biotin-peroxidase complex. Subsequently, sections
were washed in tap water, counterstained with hematoxylin,
placed in acid alcohol for 3–5 s and washed in water. Sections
were dehydrated, cleared in xylene, and finally mounted with
DEPEX. Red-brown staining indicates positive immunore-
activity. Control sections were incubated with normal serum
instead of primary antibodies. All incubation times were sim-
ilar and reactions were stopped simultaneously on sections
to standardize the quantitative methods.
For quantification of antibody staining, numbers of pos-
itive cells in every possible microscopic field in all sec-
tions were counted under high-power magnification (40×
objective). To enable comparison between sections of dif-
ferent sizes, results were expressed as number of positive
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Figure 2. Decreased langerin
expression on LP DC from
UC patients. (A) Localization of
langerin+ DC by immunohis-
tochemistry. In healthy control
sections langerin+ immature
DCs were scattered throughout
the LP while mainly tend to clus-
ter below the epithelium in sec-
tions from UC patients. (B) Cor-
responding average numbers of
all langerin+ DC per section
(C) Langerin expression (deter-
mined as IR) was also deter-
mined by flow cytometry as
explained in Fig. 1B and (D)
data displayed as the mean ±
SEM. The statistical significance
of differences between groups
was determined using unpaired
t-test and p< 0.05 was regarded
as significant (**p < 0.01).
cells per 10 microscopic fields. Only morphologically well-
defined positively stained cells were considered for analy-
sis. Intensity of DC-SIGN immunoreactivity was also quan-
tified using an arbitrary 4-point scale ranging from 0–4
(0 = no staining and 4 = intense staining). All assessments
of immunostaining were independently evaluated by two
investigators who had no previous knowledge of the clinical
data.
2.8 EM
Approximately 2 × 2 mm pieces of tissue were fixed in
0.1 mol/L sodium phosphate buffer, pH 7.4 containing 3%
glutaraldehyde for 12 h at 4C, washed in 0.1M ph 7.4 SPB
and post fixed in 1% osmium tetroxide in 0.1% pH 7.4 SPB
for 1 h. Samples were then washed and left in distilled wa-
ter to remove the phosphate for overnight and were block
stained in 2% uranyl acetate for 2–4 h. The samples were
washed with dH2O and dehydrated using an acetone gradi-
ent and gradually infiltrated with araldite resin. Araldite was
changed twice over 4–8h, then sampleswere embedded in the
araldite resin then cured for 18 h at 65C. Ultrathin sections
(100-nm-thick) were cut on a Reichert-Jung Ultracut Emicro-
tome and collected on a 200 mesh copper grid. After staining
with Reynold’s lead citrate, the grid was carbon coated and
visualized using a JEOL 1200 EX electron microscope. DCs
were identified as previously described [25–28] and have been
classified into three types by electronmicroscopy (EM): Type 1
DC; small cells with short veils relative to their size, small
cytoplasm area, and heterochromatic nuclei with thick chro-
matin layer surrounding the nucleus and chromatic dense
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Figure 3. Maturation status of DC in biopsies from healthy con-
trols and UC patients. (A) Expression levels of the inhibitory re-
ceptor ILT3, CCR7, and DC-SIGN were determined on intestinal
LP DC by flow cytometry as explained in Fig. 1B. (B) The statis-
tical significance of differences between groups was determined
using unpaired t-test and p < 0.05 was regarded as significant
(*p < 0.05, **p < 0.01, ***p < 0.001). Results are displayed as
the mean ± SEM.
clusterswithin the nucleus. Type-2DC; are bigger than type 1,
with fewer projections, thin chromatin layer surrounding the
nucleus, and disaggregated chromatin within the nucleus.
Type 3 DC; have long veiled projections and euchromatic nu-
clei. Therefore, type 1 DC can be considered as immature
DC, type 3 DC as mature, and type 2 as an intermediate
state.
2.9 Statistical analysis
Two-tailed Fisher’s exact test was applied to compare STp
presence in the colon from UC and healthy control individ-
uals. Two-way and one-way repeated measures ANOVA, and
two-tailed paired tests were applied as stated in the figure leg-
ends. In the case ofmultiple comparisons, subsequent ad hoc
Bonferroni correction was applied. p < 0.05 was considered
significant.
3 Results
3.1 Changes in intestinal DCs in UC
Intestinal DCs were isolated and characterized from healthy
controls, and UC patients in remission. Active UC pa-
tients were not studied, to assess characteristics constituting
UC-specific changes, avoiding nonspecific effects of inflam-
matory processes on DCs characterization. For phenotype
studies (characterization of DCs from UC patients and
healthy controls as displayed in Figs. 1–5) the enzymatic di-
gestion protocol was selected for the identification of DCs.
For functional studies whereDCswere culturedwith/without
STp (Figs. 6–8), the walkout culture was used for the iden-
tification of DCs following conditioning. In all cases human
intestinal DCs were identified as HLA-DR+/lineage cocktail−
cells by flow cytometry (Fig. 1A). The majority of these DCs
were CD11c+ (myeloid) cells (data not shown). In order to
avoid any subjectivity in the interpretation of the results, the
percentage and/or intensity ratio (IR) of surface expression
on intestinal DCs for each given marker were determined by
subtraction of isotype control staining from the correspond-
ing test staining (Fig. 1B and C). Figure 1D shows that LP
colonic DCs from inactive UC patients displayed a decreased
expression of costimulatory molecules CD80 and CD86 com-
pared with that in healthy control DC.
3.1.1 Reduced expression of langerin on intestinal
DCs in UC
Expression of langerin, a molecule involved in antigen cap-
ture/uptake (phagocytosis) was determined on intestinal DCs
by immunohistochemical analysis of colonic biopsies from
healthy controls and UC patients. Langerin+ DCs were lo-
cated throughout the LP in normal tissues, but tended
to be clustered below the epithelium and in deeper re-
gions of the LP in UC (Fig. 2A). All langerin+ cells were
counted; there were significantly fewer langerin+ DCs in UC
compared with healthy controls (Fig. 2B). Percentage expres-
sion of langerin per cell and IR were also determined by
flow cytometry (Fig. 2C) and results confirmed the decreased
in langerin expression on intestinal DCs from inactive UC
patients (Fig. 2D).
3.1.2 Colonic DCs are of immature status in UC
patients
Expression of inhibitory receptor IL-T3 and innate pattern
recognition receptor DC-SIGN (both characteristic of imma-
ture DCs) as well as the lymph node migration marker CCR7
were also analyzed by flow cytometry (Fig. 3A). The propor-
tion of IL-T3+ DCs was significantly increased while CCR7
expression was significantly decreased in inactive UC tissues
compared with control tissues (Fig. 3B). Levels of expression
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Figure 4. Increased DC-SIGN but not DC-LAMP on LP DC
from UC patients. (A) DC-SIGN+ DC were scattered in
the LP in healthy controls, whereas in UC was mainly
clustered in an area immediately below the epithelium.
On the contrary, DC-LAMP+ DCswere very few in number
(highlighted with black arrows) and scattered in the LP in
both control and UC tissues. A higher magnification of
DC-LAMP+ DCs is shown in the inset. (B) Corresponding
average numbers of all DC-SIGN+ and DC-LAMP+ DCs
per section. Results are displayed as the mean ± SEM.
The statistical significance of differences between groups
was determined using unpaired t-test and p < 0.05 was
regarded as significant (**p < 0.01).
of DC-SIGN per cell, measured by the positive IR, were sig-
nificantly increased in UC (Fig. 3B). Further immunohis-
tochemical analysis determined that DC-SIGN+ DCs were
scattered evenly throughout the LP in healthy controls, but
in UC were mainly clustered in an area immediately below
the epithelium close to the lumen (Fig. 4A). Numbers of DC-
SIGN+ DCs were significantly increased in UC compared
with healthy controls (Fig. 4B) in agreement with results
from flow cytometry (Fig. 3B). On the contrary, expression of
DC-LAMP, a molecule upregulated upon DCs maturation,
was minimal (Fig. 4A) and distribution did not change be-
tween healthy controls and UC patients (Fig. 4B).
3.1.3 Immature intestinal DC morphology
To further confirm the immature phenotype of intestinal DCs
in inactive UC, the maturation status of DCs was also deter-
mined by EM, as previously described [25–28]. While there
was amixture ofDCat different stages ofmaturation in all sec-
tions examined, no major difference was found in intestinal
DC morphology from healthy controls and inactive UC since
the majority of DCs in both cases were small cells with short
veils relative to their size, small cytoplasmic area, and het-
erochromatic nuclei with a thick chromatin layer surround-
ing the nucleus (including chromatic dense clusters) indicat-
ing that these cells are type 1 immature myeloid DC [25–28]
(Fig. 5) as previously suggested (Figs. 1–4).
3.2 Effects of STp on DCs in UC
In vitro experiments have previously confirmed that STp has
the capacity to modulate phenotype and function of human
DCs as well as inducing a regulatory effects on gut DCs in
healthy controls [22]. Therefore, we determined the capacity
of STp to modulate DC functions in UC patients. Intestinal
DCs were isolated and characterized from healthy controls
and patients with active UC (including both inflamed and
noninflamed areas of the colon) to determine any potential
immunomodulatory effects of STp specific to either UC or
general inflammation.
3.2.1 STp restores expression of costimulatory
molecules on DCs in UC
Similar to intestinal DC fromUC patients in remission, a sig-
nificantly lower proportion of DC from noninflamed areas of
the UC colon expressed activation molecules and costimula-
torymolecules comparedwith that in healthy controls, includ-
ing CD40 and CD80 (Fig. 6A). Conditioning such intestinal
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Figure 5. Immature intestinal DC in healthy control and UC tis-
sues. Electron micrographs of DC from the LP showing type-
1, myeloid immature DC in normal and UC colonic tissues
(Bar = 1m).
DC from UC patients with STp restored their expression of
costimulatory molecules (Fig. 6B).
3.2.2 STp reduces the aberrant expression of TLRs
on DCs in UC
TLR2 and TLR4 expression was also studied on intestinal
DC (Fig. 7A) to confirm that both markers were aberrantly
expressed on intestinal DC inUC comparedwith healthy con-
trols where their expression wasminimal (Fig. 7B). TLR4 was
enhanced on DC from both inflamed and noninflamed areas
of the gut mucosa in UC, while TLR2 was only enhanced
on DC from inflamed areas (Fig. 7B). Our data support pre-
vious studies in which it has been proposed that enhanced
expression of TLRs on intestinal DC in IBD may contribute
to the dysregulated intestinal immune response to bacterial
luminal components [11]. Conditioning intestinal DC from
UC patients with STp significantly reduced their expression
of both TLR2 and TLR4 and partially restored a normal phe-
notype (Fig. 7C).
3.2.3 STp restores the stimulatory capacity of DCs
for allogeneic T-cells in UC
Finally, we examined the capacity of STp tomodulate DC abil-
ity to generate T-cell proliferative responses during a MLR.
Following MLR, dividing T-cells were identified as CFSElo
and T-cell stimulatory capacity of DC was measured as the
proportion of dividing T-cells (stimulated with 3% DC of to-
tal T-cell numbers in all cases; Fig. 8A). DC from colonic
areas in UC (in remission) exhibited a restricted stimulatory
capacity for allogeneic T-cells, compared with their healthy
control counterparts. However, conditioning these DC with
STp restored the stimulatory capacity of DC in UC (Fig. 8B).
4 Discussion
We have analyzed the phenotype and function of human gut
DC to demonstrate for the first time, to our knowledge, that
in UC DC exhibit an immature phenotype with reduced lan-
gerin and CCR7 expression, compared to healthy controls.
Figure 6. STp effects on the
co-stimulatory molecules on in-
testinal DCs in UC. (A) Expres-
sion of activation/maturation
markers CD40 and CD80 on in-
testinal DC from inflamed (Infl)
and noninflamed (Non-infl) UC
colonic areas from the same pa-
tient, compared to colonic tis-
sue from healthy controls. (B)
CD40 and CD80 expression on
intestinal DC from noninflamed
areas treated with STp. Expres-
sion for each marker was de-
termined as in Fig. 1B and re-
sults displayed as the mean ±
SEM. The statistical significance
of differences between groups
was determined using paired t-
test and p < 0.05 was regarded
as significant (**p < 0.01).
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Figure 7. STp reduces the aber-
rant expression of TLRs on
intestinal DCs in UC. (A) Expres-
sion of TLR2 and TLR4 on in-
testinal DC was determined as
in Fig. 1B. (B) TLR2 and TLR4
expression was determined on
DC from inflamed (Infl) and non-
inflamed (Non-infl) colonic tis-
sue from UC patients compared
to healthy controls (C) Expres-
sion of TLR4 on DC from in-
flamed and noninflamed colonic
tissue and expression of TLR2
on DC from inflamed areas
of colonic UC tissue following
treatment with STp. Results are
displayed as the mean ± SEM.
The statistical significance of
differences between groupswas
determined using paired t-test
and p < 0.05 was regarded as
significant (*p < 0.05, **p <
0.01, ***p < 0.001).
Moreover, gut DC in UC exhibited a dysregulated function
in which they were less able to prime allogeneic T-cell re-
sponses compared to control DC. Our data support studies
demonstrating immature or partial DC maturation occurs in
IBD, and a reduced ability to stimulate primary T-cell prolif-
eration [29,30]. We have previously demonstrated that STp, a
peptide secreted fromprobiotic strain L. plantarum, is present
in the colon of healthy controls and has regulatory effects on
gut DC in vitro [22]. Here, we show that STp can partially
reverse the dysregulated phenotype and function of gut DC
found in UC suggesting a role in gut homeostasis for STp
that is missing in UC.
GutDCshave adapted to an environment inwhich they are
continually exposed to a huge antigenic load including com-
mensal microbiota and food antigens. Indeed, intestinal DCs
are hyporesponsive to LPS stimulation [4], thus preventing
harmful immune responses to commensal flora and provid-
ing a potential mechanism of oral tolerance [31,32]. However,
gut DC also exhibit high phagocytic capacity due to continual
uptake of antigens from the gut lumen [33]. This sampling of
harmless antigens enables tolerogenic T-cell responses to be
generated, avoiding inappropriate inflammation. It has been
proposed that some autoimmune diseases are due to nonre-
sponsiveness of DC toward antigen cross-reacting with self
(auto) antigens, that is, a lack of generated T-cell tolerance. In-
deed, DC residing within tissues with antigen cross-reacting
with auto-antigens fail to mature [34] and failure of full DC
maturation in type-1 diabetes leads to insufficient generation
C© 2013 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH Verlag GmbH & Co. KGaA Weinheim www.mnf-journal.com
Mol. Nutr. Food Res. 2014, 58, 1132–1143 1141
Figure 8. STp restores the stim-
ulatory capacity of DCs for allo-
geneic T-cells in UC. (A) Identifica-
tion of dividing T cells in aMLR and
(B) effects of STp on the stimula-
tory capacity of intestinal DC abil-
ity to generate T-cell proliferative
responses during an MLR.
of regulatory T-cell responses [35]. Our data provide a novel
mechanism for UC pathogenesis, in that loss of langerin ex-
pression on DC suggestive of loss of phagocytosis, and loss
of activation, migration and maturation may lead to reduced
ability of DC to generate potentially unresponsiveness in the
adaptive immune responses in vivo, contributing to nonspe-
cific inflammation.
UC primarily affects superficial layers of the gut mucosa,
unlike Crohn’s disease that penetrates the entire bowel wall.
Signals controlling DC position within tissues are poorly
understood, but likely to involve epithelial-derived chemo-
tactic signals [36]. The redistribution of DC-SIGN+ DC to
subepithelial sites near the lumen in UC that we
have demonstrated by immunohistochemistry is likely to
impact on antigen sampling and modulation of DC by mi-
crobial products [37]. Indeed, DC-SIGN binds various mi-
croorganisms and initiates innate immunity by modulating
TLRs [38,39]. The altered distribution of immature DC in UC
within the gut mucosa in general is likely to be indicative of
local involvement of immature DC in disease activity.
The immature phenotype of DC observed in this study
may account for the impairment of T-cell activation, result-
ing in unresponsiveness. It remains to be seen if this immune
unresponsiveness by DC would lead to anergic T-cells. These
results suggest that the molecular dialog between intestinal
bacteria and DC may be mediated by immunomodulatory
peptides secreted by commensal bacteria, rather than the
bacteria themselves [40], and implicate STp as a potential
biomarker of gut homeostasis. It has been proposed recently
that the host has no capacity to distinguish between harm-
ful pathogens and commensal bacteria themselves, but that
substrates produced by the commensal microbiota actively
promote immune tolerance to symbiotic bacteria [41]. In
agreement with that STp was found in the colonic microenvi-
ronment from 8/10 of the studied healthy controls [22], while
when studied in the colon from UC patients in the same
conditions it was only found in 3/14 patients with active UC
(controls versus UC, Fisher’s test, p= 0.011; data not shown).
Also, there was no difference regarding STp location in the
3 UC patients with detectable levels of STp since that was
found on both inflamed (descending colon) and noninflamed
areas (transversal/ascending colon) from the same patients.
Taken together this suggests that STp is not found as fre-
quently in the colon of UC patients as in that from the healthy
controls suggesting a role in gut homeostasis for STp that is
missing in UC. However, we do not know if the lack of STp
precedes development of UC or on the contrary because of
developing UC STp is missing from the colonic microenvi-
ronment from these patients.
In summary, our data indicate that as well as promoting
immune tolerance [22], STp may partially restore the regula-
tory phenotype and function of human gut DCs. TLR4 (LPS
receptor) expression was increased in UC samples but we
confirmed that STp was LPS-free as previously reported [22],
so STp effects on gut DCs are likely to be LPS independent.
If such effects can be mirrored in vivo, potential implications
C© 2013 The Authors. Molecular Nutrition & Food Research published by Wiley-VCH Verlag GmbH & Co. KGaA Weinheim www.mnf-journal.com
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are restoration of normal immune function in the gut in
UC. Bacteria-derived metabolites, like STp, seem therefore to
have a role in gut homeostasis that is missing in UC so they
might lead a new era of probiotic products setting the basis
for nondrug dietary therapy in IBD.
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